Spots Global Cancer Trial Database for A Study of Gimatecan (ST1481) in Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Gimatecan (ST1481) in Small Cell Lung Cancer
Official Title: A Phase Ib/II Study of Gimatecan (ST1481) for Small Cell Lung Cancer Patients Who Failed Standard Platinum-containing Chemotherapy
Study ID: NCT04501029
Conditions
Interventions
Study Description
Brief Summary: This phase Ib/II clinical trial studies the safety and effect of Gimatecan in small cell lung cancer patients who failed the first-line standard platinum-containing chemotherapy. The chemotherapy will be given every four weeks.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Fifth Medical Center of General Hospital of the Chinese People's Liberation Army, Beijing, Beijing, China
Contact Details
Name: LIU XIAOQING, MD
Affiliation: The Fifth Medical Center of the Chinese PLA General Hospital
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
